机器学习:瘤微环境中的免疫代谢和膀癌中的免疫治疗反应的特征
Wei Peng1, Xiaoshan Li, Shiping Wei
1Department of Urology, Yangtze River Shipping General Hospital, Hubei, China.
Journal of immunotherapy (Hagerstown, Md. : 1997)
|June 18, 2025
概括
这项研究揭示了膀癌 (BLCA) 中的主要免疫代谢 (IMB) 模式,确定了一个预测预后和免疫治疗反应的IMB.score. 突出显示UCN2基因是BLCA发育和进展的关键因素.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
背景情况:
- 免疫失调和代谢重编程是膀癌 (BLCA) 的标志.
- 免疫代谢 (IMB) 和BLCA进展之间的复杂关系尚未完全理解.
- 在BLCA中确定预后生物标志物和治疗点至关重要.
研究的目的:
- 研究BLCA中IMB相关基因的表达模式.
- 为BLCA开发基于机器学习的预后模型.
- 阐明UCN2在BLCA发病过程中的功能性作用及其与IMB的关联.
主要方法:
- 对IMB相关基因的生物信息分析.
- 机器学习模型开发用于预后预测.
- 实验验证包括qPCR,免疫组织化学,西部斑点,Transwell测定和流细胞计用于UCN2功能.
主要成果:
- 确定了两种独特的BLCA子类,具有独特的分子形状.
- 开发了一个IMB.score,与临床特征相关,并预测免疫疗法的疗效.
- 高IMB.score表明活跃的瘤微环境 (TME) 和较差的预后,但免疫治疗反应更好 (免疫潮模型).
- 在BLCA中UCN2显著过度表达,与恶性瘤和不良预后有关.
- 沉默UCN2在体外减少了BLCA细胞的增殖,迁移和入侵.
结论:
- IMB.score是预测BLCA预后和指导免疫治疗策略的宝贵工具.
- UCN2是一种关键的免疫代谢基因,与膀癌的发展,进展和恶性表型有关.
- 准UCN2可能为膀癌提供一种新的治疗方法.
相关概念视频
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K